Sandoz Losartan Potassium & Ezetimibe Drug Recall [US]

  Click to enlarge

US/Washington: Sandoz Inc., a Princeton, New Jersey establishment, recalls an estimated 636,000 Losartan Potassium Prescription Drug and Ezetimibe Prescription Drug Bottles due to suspected failure to meet child-resistant closure requirements as required by the US Poison Prevention Packaging Act and consequential risk of choking, ingestion and poisoning, all serious health and safety hazards.

CPSC: http://ht.ly/2wC230proqE

Direct link: https://www.cpsc.gov/Recalls/2019/Sandoz-Recalls-Losartan-Potassium-and-Ezetimibe-Prescription-Drug-Bottles-Due-to-Failure-to-Meet-ChildResistant-Closure-Requirements

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves Bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain identified batch/lot numbers.

Sandoz Australia Curam Duo Antibiotic Recall [Australia]

Australia/Canberra: Sandoz Australia Pty Limited, a Macquarie Park, New South Wales establishment, recalls certain batch/lots of Curam Duo 400/57 Antibiotic Powder for Oral Suspension due to suspected air and moisture penetration with consequential risk of bacterial and/or viral contamination, severe illness and/or possible life-changing complications, all serious health hazards.

ACCC: http://ht.ly/qksr30oQm9l

Direct link: https://www.productsafety.gov.au/recall/sandoz-australia-pty-limited-curam-duo-400-57-powder-for-oral-suspension

Additional information:
The Australian Competition & Consumer Commission (“ACCC”) reports the following Antibiotic Powder products are subject to this recall:

Sandoz & Novartis Drug Blister Package Recall [US]

US/Washington: Sandoz and Novartis recall an estimated 470,000 Prescription Drug Blister Packages due to suspected failure to meet child-resistant closure requirements as required by the US Poison Prevention Packaging Act and consequential risk of choking, ingestion and poisoning, all serious health and safety hazards.

CPSC: http://ht.ly/qXyk30kR2SM

Direct link: https://www.cpsc.gov/Recalls/2018/Sandoz-and-Novartis-Recall-Prescription-Drug-Blister-Packages-Due-to-Failure-to-Meet-Child-Resistant-Closure-Requirements

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves certain Blister Packages of various Prescription Drugs branded by Novartis and Sandoz. The Drugs are packaged with three (3) to ten (10) tablets per blister card.

Introvale Oral Contraceptive Recall

US/Silver Spring: Sandoz recalls some Introvale Oral Contraceptives due to packaging flaw hazard. FDA: http://ht.ly/bsmyh

Direct link: http://www.fda.gov/Safety/Recalls/ucm307098.htm